Search

everythinglearnresearchcommunity

for

Search:↓

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Smoking harms the skin, causing early aging and increasing cancer risk, but stopping smoking can improve skin health.

Postinflammatory hyperpigmentation causes dark skin patches and needs personalized treatment.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Skin diseases differ between Ghana and the UK, with infections most common in Ghana and malignant skin diseases most prevalent in the UK.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Mycophenolate mofetil was effective for most patients in treating scarring hair loss, but some had side effects.

The 308-nm excimer laser is a promising treatment for vitiligo with varying success and mild side effects.

Certain fungi and bacteria help orchid seeds germinate and plants grow better.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Artesunate is generally safe for severe malaria, but patients should be monitored for delayed anemia after treatment.

Eclipta alba has many health benefits and contains compounds with potential for drug development.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Autophagy is important for human hair growth and health.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

New drug delivery methods can make natural compounds more effective and stable.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.